(Q71246278)

English

A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer

scientific article published on 01 January 1983

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R V Smalley

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

J Lefante

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

A Bartolucci

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

J Carpenter

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

C Vogel

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

S Krauss

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 January 1983

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

209-220

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

https://scigraph.springernature.com/pub.10.1007/bf01803563

0 references

Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast tumor modeling for prognosis and treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclical Combination Chemotherapy for Advanced Breast Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced breast cancer with bone-only metastases: a chemotherapeutically responsive pattern of metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination cytotoxic chemotherapy in advanced disseminated breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined chemoimmunotherapy for advanced breast cancer.A comparison of BCG and levamisole

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of disseminated breast cancer:Current status and prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard

1 reference

https://pubmed.ncbi.nlm.nih.gov/6688538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01803563

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688538%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71246278&oldid=1966928249"